Abstract:Background Although surgical resection or amputation has been the mainstay of localized chondrosarcoma management for many decades, its efficacy in patients with metastatic chondrosarcoma remains unknown, and likewise we do not know whether there are any tumor-or patient-related factors associated with better survival after surgery for metastatic chondrosarcoma. Questions/purposes (1) Is resection of the primary tumor associated with improved survival in patients with metastatic chondrosarcoma? (2) Which subgroups of patients with chondrosarcoma benefit more from resection in terms of survival? Methods We identified 200 of 222 patients with metastatic chondrosarcoma in the Surveillance, Epidemiology, and End Results (SEER) database between 1988 and 2014 based on the exclusion criteria. Among those patients, 107 (53.5%) underwent primary tumor resection or amputation. Patient information, including demographics (patient age, gender, race, year of diagnosis), tumor characteristics (primary site, histologic subtype, tumor grade, tumor size), and treatment (record of operation and radiation), was collected and included in the study. Kaplan-Meier analyses, log-rank tests, competing risks framework, multivariable Cox regression modeling, and interaction tests were conducted to assess the association of primary tumor resection and survival in the overall cohort and subgroups. Results Resection of the primary tumor was associated with improved overall survival (hazard ratio [HR], 0.481; 95% confidence interval [CI], 0.340-0.680; p < 0.001) and cancer-specific survival (HR, 0.493; 95% CI, 0.343-0.709; p < 0.001) after controlling for confounding variables. After controlling further for age, histologic subtype, and grade, primary tumor resection was associated with a survival advantage in patients with conventional subtype and Grade II chondrosarcoma (conventional subtype: HR, 0.403; 95% CI, 0.260-0.623 for overall survival and HR, 0.396; 95% CI, 0.250-0.627 for cancer-specific survival). However, primary tumor resection was not associated with increased survival in patients with metastatic chondrosarcoma who had the dedifferentiated subtype and Grade III malignancy. Conclusions The present study demonstrates a possible favorable association between primary tumor resection and survival in some patients with metastatic chondrosarcoma at initial diagnosis. Specifically, patients with conventional subtypes and Grade II malignancies who underwent primary tumor resection had better survival compared with those patients who did not have primary tumor resection. Thus, there might be a benefit from primary tumor resection in these patients, but given the limitations of this database, further prospective studies or randomized trials are needed to confirm our findings. In the meantime, this information might be helpful to consider when discussing surgical options with patients who have conventional, Grade 2 metastatic chondrosarcoma at diagnosis. Level of Evidence Level III, therapeutic study.

Primary tumor surgery improves survival of cancer patients with synchronous solitary bone metastasis: a large population-based study

Surgery for primary tumor benefits survival for breast cancer patients with bone metastases: a large cohort retrospective study

Sites of Synchronous Distant Metastases and Prognosis in Prostate Cancer Patients with Bone Metastases at Initial Diagnosis: a Population-Based Study of 16,643 Patients.

Predicting Survival of Patients with Bone Metastasis of Unknown Origin

Influence of Primary Tumor Resection on Survival of Patients with Metastatic Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Analysis

Does Resection of the Primary Tumor Improve Survival in Patients With Metastatic Chondrosarcoma?

Risk factors and prognosis of surgery for spinal metastasis

Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients with Synchronous Bone Metastasis.

Prognostic Value of Primary Tumor Surgery in De Novo Stage IV Breast Cancer Patients with Different Metastatic Burdens: a Propensity Score-Matched and Population-Based Study

Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population‐based study

Resection of the Primary Tumor and Survival in Patients with Single-Site Synchronous Oligometastatic Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Database

Hormone Receptor Status May Impact The Survival Benefit Of Surgery In Stage Iv Breast Cancer: A Population-Based Study

Outcomes of surgery for gastric cancer with distant metastases: a retrospective study from the SEER database.

Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients.

Local Surgery Improves Survival in Patients with Primary Metastatic Breast Cancer: A Population-Based Study.

Surgical resection of primary tumor in the extremities improves survival for metastatic soft-tissue sarcoma patients: a population-based study of the SEER database

Clinical Features and Serological Markers Risk Model Predicts Overall Survival in Patients Undergoing Breast Cancer and Bone Metastasis Surgeries

Surgical Resection of Primary Tumor for Bone Metastatic Breast Cancer Patients at Initial Presentation

Surgical Resection of a Primary Tumor Improves Survival of Metastatic Pancreatic Cancer: a Population-Based Study.

Assessing Surgical Benefits and Creating a Prognostic Model for Breast Cancer with Lung-only Metastasis: An Analysis of the National Cancer Database

Prognostic Value Of Primary Tumor Surgery In Seminoma Patients With Distant Metastasis At Diagnosis: A Population-Based Study